fibrinogen has been researched along with Cancer of Endometrium in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, DL; Jackson, D; Kirkham, J; Price, M; Riley, RD; Salanti, G; White, IR | 1 |
Giorda, G; Guido, M; Malvasi, A; Mynbaev, OA; Nezhat, FR; Tinelli, A; Tsin, DA | 1 |
Casarin, J; Cimetti, L; Cromi, A; Deleonibus, S; Ghezzi, F; Passi, A; Riva, C; Uccella, S; Vigetti, D | 1 |
Wang, H; Wang, X; Zhou, X | 1 |
Grimm, C; Hefler, L; Hefler-Frischmuth, K; Husslein, H; Leipold, H; Polterauer, S; Reinthaller, A; Seebacher, V; Tempfer, C | 1 |
Cromi, A; Formenti, G; Franchi, M; Ghezzi, F; Giudici, S; Serati, M; Siesto, G | 1 |
De Iaco, P; Di Marcoberardino, B; Orazi, L; Pozzati, F; Ricci Maccarini, L; Rossi, M; Strada, I; Tsivian, M; Venturoli, S | 1 |
Dell'Edera, D; Giorda, G; Guido, M; Malvasi, A; Manca, C; Pellegrino, M; Prudenzano, R; Tinelli, A | 1 |
Heilmann, L; Hommel, G; Pollow, K; von Tempelhoff, GF | 1 |
Baba, M; Kobayashi, T; Matsushita, H; Monden, T; Osawa, H; Shimano, T; Takeda, T; Tamaki, Y; Tsuji, Y; Yagyu, T | 1 |
Eichinger, S; Gisslinger, H; Hattey, E; Knöbl, P; Mitterbauer, GJ; Mitterbauer, M; Speiser, W; Weltermann, A | 1 |
Aisaka, K; Kaibara, M; Liang, SG; Okinaga, S; Ooka, F; Watanabe, T | 1 |
2 trial(s) available for fibrinogen and Cancer of Endometrium
Article | Year |
---|---|
Lymphocele prevention after pelvic laparoscopic lymphadenectomy by a collagen patch coated with human coagulation factors: a matched case-control study.
Topics: Blood Coagulation Factors; Case-Control Studies; Drug Combinations; Endometrial Neoplasms; Female; Fibrinogen; Follow-Up Studies; Humans; Laparoscopy; Lymph Node Excision; Lymphocele; Middle Aged; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Pelvis; Postoperative Complications; Prognosis; Surgical Sponges; Thrombin | 2013 |
Prevention of lymphocele in female pelvic lymphadenectomy by a collagen patch coated with the human coagulation factors: a pilot study.
Topics: Blood Coagulation Factors; Collagen; Drug Combinations; Endometrial Neoplasms; Female; Fibrinogen; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphocele; Middle Aged; Neoplasm Staging; Pelvis; Pilot Projects; Postoperative Complications; Prognosis; Prospective Studies; Surgical Sponges; Thrombin | 2012 |
10 other study(ies) available for fibrinogen and Cancer of Endometrium
Article | Year |
---|---|
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
Topics: Antineoplastic Agents, Hormonal; Cardiovascular Diseases; Clinical Trials as Topic; Endometrial Neoplasms; Female; Fibrinogen; Humans; Multivariate Analysis; Myocardial Infarction; Network Meta-Analysis; Progesterone; Thrombolytic Therapy; Treatment Outcome | 2017 |
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Endometrial Neoplasms; Female; Fibrinogen; Humans; Immunohistochemistry; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.
Topics: Adenocarcinoma; CA-125 Antigen; Case-Control Studies; Endometrial Neoplasms; Female; Fibrinogen; Humans; Logistic Models; Lymphatic Metastasis; Middle Aged; Retrospective Studies; Risk; ROC Curve; Sensitivity and Specificity | 2017 |
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.
Topics: Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fibrinogen; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Analysis | 2010 |
Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Endometrial Neoplasms; Female; Fibrinogen; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Retrospective Studies | 2010 |
[Fibrinogen and thrombin coated patch use on collagen support for lymphocele prevention after lumbar-aortic lymphadenectomy in gynecological neoplasms].
Topics: Adult; Carcinoma; Collagen; Drug Combinations; Endometrial Neoplasms; Female; Fibrinogen; Genital Neoplasms, Female; Hemostatics; Humans; Hysterectomy, Vaginal; Lumbosacral Region; Lymph Node Excision; Lymphocele; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pelvis; Surgical Sponges; Thrombin; Time Factors; Treatment Outcome | 2011 |
Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancer.
Topics: Aged; Biomarkers; Blood Viscosity; Brachytherapy; Cell Hypoxia; Combined Modality Therapy; Endometrial Neoplasms; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hysterectomy; Leukocyte Count; Middle Aged; Platelet Count; Radiotherapy, Adjuvant; Uterine Cervical Neoplasms | 2004 |
A cancer-reactive human monoclonal antibody derived from a colonic cancer patient treated with local immunotherapy.
Topics: Adenoma; Antibodies, Monoclonal; B-Lymphocytes; Carbohydrate Conformation; Carbohydrate Sequence; Cell Fusion; Cell Line; Colonic Neoplasms; Endometrial Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Glycolipids; Humans; Immunotherapy; Lymph Nodes; Lymphocytes; Molecular Sequence Data; Picibanil; Stomach Neoplasms | 1993 |
[Disseminated intravascular coagulation (DIG) with massive hyperfibrinolysis in metastatic uterine cancer. Observations on the effects on the coagulopathy of various treatments (a case report)].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Deoxycytidine; Disseminated Intravascular Coagulation; Endometrial Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Gemcitabine; Humans; Middle Aged; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1998 |
Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Blood Viscosity; Combined Modality Therapy; Endometrial Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematocrit; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Platelet Count; Risk; Thrombophilia | 2001 |